Anticorpos Monoclonais — Tratamento para Alergia Alimentar — Alergia a Amendoim

Reading time: 10 min
WhatsApp ↗
Medical Encyclopedia · Allergy and Clinical Immunology

Anticorpos Monoclonais — Tratamento para Alergia Alimentar — Alergia a Amendoim

Clinical Summary and Overview

The manifestations associated with Food Allergy These issues raise important clinical questions and require specialized guidance to avoid the risks of self-medication or unnecessary restrictions. When addressing the topic "Anticorpos Monoclonais — Tratamento para Alergia Alimentar — Alergia a Amendoim"This educational guide brings together the practical knowledge of the medical team from the Brazil Without Allergies Project in order to clarify the triggering factors, the most accurate diagnostic tests, and the modern therapeutic strategies currently available.

✔ Medical content reviewed and validated by the founding clinical staff of the Brazil Without Allergies Project

Dr. Marcello Bossois (CRM-RJ 52.73214-1) · Dr. Patricia Schlinkert (CRM/RJ 5274541-3) — more than 30 years of history in Allergy and Immunology, with units in Rio de Janeiro, São Paulo and Paraná. Last reviewed: November 2026.

Anticorpos Monoclonais — Tratamento para Alergia Alimentar — Alergia a Amendoim

Avanços no Tratamento da Alergia a Amendoim e o Papel dos Anticorpos Monoclonais

A alergia alimentar severa, especialmente a substâncias como o amendoim, representa um desafio clínico significativo para os pacientes afetados. Em quadros de hipersensibilidade grave, o simples contato cruzado com traços do alimento — muitas vezes decorrente do processamento em máquinas compartilhadas — pode desencadear reações sistêmicas intensas, colocando a vida do paciente em risco. Diante dessa realidade, a pesquisa médica internacional busca continuamente novas alternativas terapêuticas para modificar a história natural da doença e oferecer maior segurança.

Nesse contexto de inovação, estudos experimentais têm investigado o uso de terapias biológicas direcionadas, como os anticorpos monoclonais voltados contra a interleucina-33 (anti-interleucina-33). A interleucina-33 é uma substância sinalizadora intimamente relacionada aos mecanismos imunológicos do perfil Th2, que desempenham um papel central nas respostas alérgicas e na produção de anticorpos da classe IgE. A correlação entre a inibição dessa via e a modulação das alergias alimentares tem sido objeto de intensa investigação científica, principalmente em países como os Estados Unidos, onde o consumo frequente de amendoim impulsiona a necessidade de novas abordagens terapêuticas.

Discussões recentes com especialistas internacionais na área de alergologia e imunologia também apontam para fatores ambientais que podem influenciar o aumento exponencial das alergias alimentares em determinadas regiões. Observa-se que fatores como o uso de defensivos agrícolas podem alterar o reconhecimento de porções proteicas específicas e epítopos antigênicos pelo sistema imunológico, favorecendo o desencadeamento de reações de hiperreatividade. É por essa razão que o amendoim e outros alimentos comuns na dieta norte-americana figuram no centro de importantes protocolos de pesquisa clínica.

Apesar de os estudos com medicamentos anti-interleucina-33 mostrarem-se altamente promissores no horizonte da imunologia, é fundamental destacar que essas alternativas ainda se encontram em fase de investigação científica e não estão comercialmente disponíveis para prescrição médica rotineira. Este conteúdo possui caráter estritamente educativo e informativo, não substituindo em hipótese alguma a consulta, o diagnóstico e o acompanhamento individualizado com um médico especialista em Alergia e Imunologia.

Developments in Evidence-Based Medicine: Differential Diagnosis between Food Allergy and Intolerances

The international guidelines on Food Allergy and Gastroenterology (EAACI/ASBAI) emphasize the precise pathophysiological distinction between immune-mediated food allergy — directed against specific protein fractions in food (such as casein, alpha-lactalbumin, and beta-lactoglobulin in cow's milk protein allergy; ovomucoid in eggs; or tropomyosin in crustaceans), which may be IgE-mediated (risk of immediate anaphylaxis), non-IgE-mediated, or mixed (as in eosinophilic esophagitis and allergic proctocolitis) — and enzymatic or fermentative food intolerances (such as hypolactasia/lactose intolerance and visceral hypersensitivity to fermentable carbohydrates FODMAPs), which do not involve an immune response or anaphylactic risk. The gold standard diagnosis relies on clinical history, specific IgE for molecular components (Component-Resolved Diagnostics), skin tests and, when indicated, oral provocation test (OPT) supervised, avoiding unnecessary restrictive diets.

💎 Diamond Plan — Eating safely and without fear of adverse reactions starts with an accurate diagnosis. Speak with an Allergy and Immunology specialist via teleconsultation, from anywhere in Brazil. Schedule a teleconsultation →

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Mechanisms of Food Allergy, Accurate Diagnosis and Nutritional Management

IgE-Mediated Allergy, Mixed Allergy, and Difference from Enzyme Intolerances

The immune system associated with the gastrointestinal mucosa normally functions by maintaining oral tolerance to thousands of dietary proteins. When this immune barrier is broken—influenced by genetic predisposition, dysbiosis of the intestinal microbiota, or immaturity of secretory IgA in childhood—intact protein fractions sensitize mast cells and basophils. Therefore, a single positive blood test reflects only biological sensitization and should always be correlated with the clinical history and, when necessary, with a supervised oral food challenge in a medical setting.

Label Reading, Desensitization, and Food Safety

Avoiding restrictive, empirically based diets without diagnostic confirmation prevents significant nutritional deficiencies, especially in growing children. Proper investigation includes... allergy test specific for protein fractions and protocols of vaccine for milk allergy conducted by specialists. In selected and rigorously monitored cases, modern resources are used. allergy vaccine They complement the comprehensive care of the atopic patient.

Selective Blockade of Cytokines (IL-4, IL-5, IL-13, TSLP) and Immunoglobulin E

Monoclonal antibodies (immunobiologics) have revolutionized the management of severe allergic and immune-mediated diseases that do not achieve full control with conventional therapies. Unlike systemic corticosteroids and classic immunosuppressants—which broadly depress immunity and generate metabolic toxicity—immunobiologics act as highly precise molecular keys, neutralizing specific targets of the inflammatory cascade: such as circulating free IgE (omalizumab), the IL-4 and IL-13 receptor (dupilumab), the eosinophilic pathway of IL-5 (mepolizumab and benralizumab), or the epithelial alarmin TSLP (tezepelumab).

Diamond Plan: Specialized Allergy Treatment Wherever You Are

SIGNATURE
DIAMOND

Allergy-Free Brazil

THE FUTURE OF TREATMENT

💎

  • Allergy and immunostimulant vaccines included.
  • Easy access (upon request)
  • Nationwide coverage — all of Brazil

brasilsemalergia.online

We know that, for many families, allergy treatment faces two concrete obstacles: high cost of allergy vaccines and the distance to a specialized centerThe Diamond Plan It was created precisely to remove these barriers, combining teleconsultation with specialists and easy access to immunotherapy throughout the country. Eating safely and without fear of reactions starts with an accurate diagnosis.

Why do patients across Brazil choose the Diamond Plan?

  • Teleconsultation with a specialist In Allergy and Immunology, without queues and without long commutes — ideal for those who live far from large cities.
  • easy access to Immunotherapy (including allergy vaccines and immunostimulants) — indicated for the treatment of allergic rhinitis, asthma, bronchitis, atopic dermatitis, insect/mosquito bite allergy (prurigo strophulus), recurrent candidiasis, and for increasing immunity in selected patients — capable of modifying the natural course of allergic disease, always through consultation and individualized prescription.
  • A more accessible route For those facing the high cost of allergy vaccines, this plan offers support for continuity of treatment.
  • Continuous monitoring based on clinical evolution, with adjustments to treatment throughout the entire therapeutic cycle.
  • National coverage, backed by a consolidated physical network and a founding clinical team with over three decades of experience.

More than 30 years caring for people with allergies.

Founded and run by Dr. Marcello Bossois (CRM-RJ 52.73214-1) and by Dr. Patrícia Schlinkert (CRM/RJ 5274541-3)The Brazil Without Allergies Project adds... more than 30 years of history and more than 450,000 free services, with physical presence at Rio de Janeiro, São Paulo and Paraná, one mobile clinic bus that brings testing and consultations to communities with limited access to specialized care and a platform of telemedicine which connects patients from all states to the same standard of care.

START TODAY

Your expert consultation is just a click away.

I want to join the Diamond Plan.Schedule a teleconsultation

Official telemedicine environment: brasilsemalergia.online

Do you prefer to be served in person?

Our clinical units They conduct consultations, allergy tests, and immunotherapy follow-up with doctors in person:

Schedule your in-person appointment. Or check the mobile bus schedule through the customer service center on WhatsApp. (21) 99954-5632.

The indication for immunotherapy, and for any treatment, depends on an individual medical evaluation. This content is for informational purposes only and does not replace consultation with a specialist.

Note: Subject to prior medical evaluation (in person or via telemetry/telemedicine). Immunotherapy uses allergen-specific vaccines, which requires a prescription from the attending physician and must be administered under direct medical supervision.

Conclusion and Summary of Guidelines

It is concluded that the efficient management of issues related to Food Allergy It relies on the combination of high-quality scientific information, environmental prevention, and therapy tailored to each patient's profile. In the face of persistent or recurring symptoms, seeking evaluation with an allergist and immunologist—integrating thorough diagnostic investigation and established options for specialized allergy and immunology care whenever indicated—ensures clinical safety and lasting health protection.

Scientific references and authoritative sources

The guidelines on this page follow the guidelines and literature of leading international Allergy and Immunology institutions. For further information: